Skip to main content
. 2012 Dec;343(3):587–595. doi: 10.1124/jpet.111.191288

Fig. 2.

Fig. 2.

Administration of GS-6201, given immediately after coronary ligation (4 mg/kg i.p. twice daily), prevented caspase-1 activation in the heart tissue measured 72 h after surgery and significantly inhibited leukocyte (CD45+) recruitment in the heart. *, P < 0.001 versus sham; #, P < 0.01 versus vehicle (n = 4–6 per group).